This study assessed uptake of COVID‐19 vaccines and intention to vaccinate and associated factors in the Democratic Republic of the Congo.
Abstract
COVID‐19 pandemic caused significant mortality and morbidity locally and globally. Vaccines were introduced as the most effective medical countermeasure against severe morbidity, hospitalization, and death. However, vaccine uptake remains suboptimal in many countries in Sub‐Saharan Africa. This study assessed uptake of COVID‐19 vaccines and intention to vaccinate and associated factors in the Democratic Republic of the Congo.
This systematic review and meta‐analysis protocol aims to critically evaluate the available evidence from randomized and nonrandomized clinical trials regarding the effectiveness, safety, and immunogenicity of the second COVID‐19 vaccine booster in older adults worldwide.
Marieli Thomazini Piske Garcia, V. Valim, L. C. Lopes-Júnior· Health Science Reports· 0 citations
Protection against severe disease and real-world VE studies from the Omicron era further indicated comparable or improved protection against hospitalization and severe outcomes with heterologous boosting compared to homologous combinations.
Early vaccine coverage was achieved, but uptake was insufficient to meet national coverage targets, supporting dual-framework implementation science for evaluating large-scale public health interventions to inform health system strengthening and emergency preparedness.
Ilona Matthew, M. Viljoen, Jane McCartney· African Journal of Primary H...· 0 citations
As the Bundibugyo Ebola virus outbreak continues to spread in the Democratic Republic of the Congo, the first of four vaccine candidates has entered clinical trials. Katharine Lang reports on what is known about them and the UK’s key role in the trials
Katharine Lang· British medical journal· 2 citations
A review was planned to review policy-level factors determining starting COVID-19 vaccination among children, taking into account their lower biological reserve and their being less likely to follow the non-pharmacological interventions.
H. S. Joshi, Anand Mohan Dixit, A. Koparkar et al.· Journal of Health Management· 0 citations
This data indicates that influenza vaccine effectiveness against laboratory‐confirmed influenza‐associated hospitalisation among patients in Northern Ireland during the 2024/25 influenza season will be lower than expected.
Magda Bucholc, S. Murphy, Mark G. O'Doherty et al.· Influenza and Other Respirat...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.